Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A10482 | Pages: NA | Charts: NA | Tables: NA |
Clinical perinatal software comprises features such as advanced statistical analysis, which is improving the clinical efficiency as well as standardization of care at the time of childbirth. Clinical perinatal software offers constant analysis as well as well-organized display of real-time complex data for encouraging better human recognition and communication concerning the difficulties at the time of labor. The clinical perinatal software is used to interpret relationship between maternal labor and the heart rate of the fetus during pregnancy, labor, and delivery to represent it graphically. It can monitor the health of both fetus and pregnant woman and helps healthcare professionals to be prepared for any complexity that would arise during the prenatal period. These software help to reduce any life threatening and other harmful circumstances for both baby and mother by evaluating the health condition, thereby resulting in safe delivery and good health of baby and mother.
COVID-19 scenario analysis
Pharmaceutical and biotechnological companies together with governments around the globe are working to combat with the COVID-19 outbreak, from supporting the development of vaccines to schedule for medicines supply chain challenges. Furthermore, there are around 115 vaccine candidates and other 155 molecules that are kept in the R&D pipeline in the coming years. Moreover, commonly used drugs such as hydroxychloroquine have seen huge boost in demand for the management of COVID-19. Furthermore, increase has been witnessed in the demand for drugs, which is likely to offer remunerative opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is anticipated to witness a substantial growth in the next few years.
Top impacting factors: market scenario analysis, trends, drivers, and impact analysis
The major factors affecting the industry include surge in the birth rates along with increase in the number of post-date pregnancy. The advancements and upgradation in the technologies are predicted to help the industry gain traction in coming years. Furthermore, surge in the adoption of IT in healthcare sector is propelling the clinical perinatal software market growth. Moreover, increase in the healthcare spending across the globe along with surge in government awareness programs regarding the prenatal birth problems are projected to help the industry gain higher revenue during the forecast period.
Rise in the number of births
Increase in the number of births would help the industry flourish throughout the forecast period. For instance, in 2018, according to the National Center of Health Statistics, the total number of new births is around 3,791,712 per year, i.e., the birth rate is 11.6 per 1,000 population. Furthermore, the average fertility rate is about 59.1 births per 1,000 women aged 15-44 years. This is anticipated to help the clinical perinatal software market to flourish over the next few years.
Surge in number of mergers and acquisitions
Increase in the number of mergers and acquisitions is anticipated to help the industry boost in the coming years. For instance, in December 2019, LABORIE Medical Technologies, a leading global developer and manufacturer of medical diagnostics and devices in the pelvic health and gastroenterology, announced the execution of a definitive agreement to acquire Clinical Innovations for an enterprise value of $525 million.
Clinical innovations is a leading global provider of clinician-preferred medical devices for the labor & delivery (L&D) and neonatal intensive care unit (NICU) specialties. The acquisition of Clinical Innovations supports the successful evolution of the business and advances LABORIE's strategy to invest in market leading technologies that address high growth medical specialties, delivering clinical, access and/or economic advantages. Clinical Innovations provides LABORIE with a strong global presence in the L&D and NICU specialties, and the company's diversified and differentiated market-leading product portfolio makes a difference for clinicians and their patients. Clinical Innovations is based in Salt Lake City with additional sales and logistics satellite offices in the U.S., Europe, Australia, and China.
Key benefits of the report
Questions answered in the clinical perinatal software market research report:
Key Market Segments
Key Market Players